Holen Sie sich die Stockscreener-App
30.65
2.94%
-0.93
Handel nachbörslich:
30.63
-0.02
-0.07%
Schlusskurs vom Vortag:
$31.58
Offen:
$31.58
24-Stunden-Volumen:
658.51K
Relative Volume:
0.95
Marktkapitalisierung:
$549.78M
Einnahmen:
$116.88M
Nettoeinkommen (Verlust:
$-25.09M
KGV:
-218.93
EPS:
-0.14
Netto-Cashflow:
$-20.74M
1W Leistung:
+3.62%
1M Leistung:
+7.39%
6M Leistung:
+58.32%
1J Leistung:
+115.85%
1-Tages-Spanne:
$29.64
$31.70
1-Wochen-Bereich:
$29.14
$32.90
52-Wochen-Spanne:
$13.91
$43.72
Rigel Pharmaceuticals Stock (RIGL) Company Profile
Firmenname
Rigel Pharmaceuticals
Sektor
Branche
Telefon
650-624-1100
Adresse
611 GATEWAY BOULEVARD, SUITE 900, SOUTH SAN FRANCISCO, CA
Vergleichen Sie RIGL mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
RIGL
Rigel Pharmaceuticals
|
30.65 | 566.46M | 116.88M | -25.09M | -20.74M | -0.14 |
|
VRTX
Vertex Pharmaceuticals Inc
|
426.00 | 109.11B | 11.39B | 3.64B | 3.50B | 13.99 |
|
REGN
Regeneron Pharmaceuticals Inc
|
642.25 | 68.50B | 14.25B | 4.58B | 3.88B | 41.77 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
434.07 | 60.25B | 3.21B | 43.57M | 221.36M | 0.2405 |
|
ARGX
Argen X Se Adr
|
826.28 | 50.39B | 3.06B | 1.28B | 447.35M | 19.67 |
|
INSM
Insmed Inc
|
186.23 | 40.44B | 447.02M | -1.18B | -868.57M | -6.1812 |
Rigel Pharmaceuticals Stock (RIGL) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2023-04-03 | Fortgesetzt | Piper Sandler | Neutral |
| 2022-06-09 | Herabstufung | Citigroup | Buy → Neutral |
| 2022-06-08 | Herabstufung | Cantor Fitzgerald | Overweight → Neutral |
| 2022-06-08 | Herabstufung | Piper Sandler | Overweight → Neutral |
| 2022-03-23 | Eingeleitet | B. Riley Securities | Neutral |
| 2020-11-09 | Herabstufung | JP Morgan | Overweight → Neutral |
| 2019-11-15 | Fortgesetzt | Cantor Fitzgerald | Overweight |
| 2019-09-26 | Fortgesetzt | JP Morgan | Overweight |
| 2019-03-01 | Bestätigt | Cantor Fitzgerald | Overweight |
| 2018-08-27 | Eingeleitet | Citigroup | Buy |
| 2018-05-02 | Bestätigt | Cantor Fitzgerald | Overweight |
| 2017-12-21 | Fortgesetzt | Piper Jaffray | Overweight |
| 2017-12-15 | Eingeleitet | Cantor Fitzgerald | Overweight |
| 2017-11-06 | Fortgesetzt | H.C. Wainwright | Buy |
| 2017-03-09 | Bestätigt | H.C. Wainwright | Buy |
| 2016-08-31 | Bestätigt | H.C. Wainwright | Buy |
| 2016-08-30 | Bestätigt | Piper Jaffray | Overweight |
| 2016-07-13 | Eingeleitet | H.C. Wainwright | Buy |
| 2016-06-13 | Eingeleitet | Piper Jaffray | Overweight |
| 2016-04-22 | Hochstufung | JP Morgan | Neutral → Overweight |
| 2013-04-08 | Bestätigt | Stifel | Buy |
| 2012-11-29 | Eingeleitet | UBS | Neutral |
| 2012-11-06 | Bestätigt | Oppenheimer | Outperform |
| 2012-03-26 | Eingeleitet | Canaccord Genuity | Hold |
| 2010-12-10 | Herabstufung | MP Advisors | Outperform → Market Perform |
Alle ansehen
Rigel Pharmaceuticals Aktie (RIGL) Neueste Nachrichten
Rigel Pharmaceuticals (RIGL) Set for Q3 Earnings Announcement - GuruFocus
Can Rigel Pharmaceuticals Inc. stock hit analyst price targetsJuly 2025 Closing Moves & AI Powered Buy/Sell Recommendations - newser.com
What is the fair value estimate for Rigel Pharmaceuticals Inc. (RI2) stock in 2025July 2025 Catalysts & Risk Controlled Stock Pick Alerts - newser.com
Will Rigel Pharmaceuticals Inc. (RI2) stock split increase liquidity2025 Breakouts & Breakdowns & High Accuracy Swing Trade Signals - newser.com
Rigel Announces One Oral and Four Poster Presentations at the 67th American Society of Hematology Annual Meeting and Exposition - PR Newswire
Will Rigel Pharmaceuticals Inc. (RI2) stock enhance shareholder valueGap Down & Weekly Setup with High ROI Potential - newser.com
Rigel Pharmaceuticals Inc (RIGL) Q3 2025 Earnings Report Preview: What to Expect - GuruFocus
Will Rigel Pharmaceuticals Inc. stock reach Wall Street targetsWeekly Trade Review & Long-Term Capital Growth Ideas - newser.com
Can you recover from losses in Rigel Pharmaceuticals Inc.2025 Investor Takeaways & Daily Technical Stock Forecast Reports - newser.com
Why Rigel Pharmaceuticals Inc. stock remains undervaluedMarket Sentiment Report & Real-Time Market Sentiment Alerts - newser.com
Will earnings trigger a reversal in Rigel Pharmaceuticals Inc.2025 Market Overview & Weekly High Return Opportunities - newser.com
Can a trend reversal in Rigel Pharmaceuticals Inc. lead to recoveryExit Point & AI Driven Price Predictions - newser.com
Can Rigel Pharmaceuticals Inc. (RI2) stock ride next bull market cyclePortfolio Value Summary & AI Forecasted Stock Moves - newser.com
How Rigel Pharmaceuticals Inc. stock responds to policy changesAnalyst Upgrade & Short-Term High Return Strategies - newser.com
Candlestick signals on Rigel Pharmaceuticals Inc. stock today2025 Bull vs Bear & Verified Entry Point Detection - newser.com
Will Rigel Pharmaceuticals Inc. (RI2) stock outperform value peersJuly 2025 Action & Smart Allocation Stock Tips - newser.com
What insider trading reveals about Rigel Pharmaceuticals Inc. stock2025 Institutional Moves & Weekly Setup with High ROI Potential - newser.com
How Rigel Pharmaceuticals Inc. stock performs in high volatility marketsWeekly Profit Report & High Return Trade Guides - newser.com
Detecting price anomalies in Rigel Pharmaceuticals Inc. with AI2025 Market Sentiment & Fast Entry High Yield Tips - newser.com
Is Rigel Pharmaceuticals Inc. stock a contrarian buyRate Cut & Expert Curated Trade Setup Alerts - newser.com
What momentum shifts mean for Rigel Pharmaceuticals Inc.Trade Entry Summary & Long-Term Safe Investment Ideas - newser.com
Why pension funds invest in Rigel Pharmaceuticals Inc. (RI2) stock2025 Risk Factors & Consistent Growth Equity Picks - newser.com
Why Rigel Pharmaceuticals Inc. stock could see breakout soonQuarterly Portfolio Review & High Conviction Buy Zone Alerts - newser.com
What machine learning models say about Rigel Pharmaceuticals Inc.July 2025 News Drivers & Verified Swing Trading Watchlist - newser.com
News impact scoring models applied to Rigel Pharmaceuticals Inc.2025 Volatility Report & Free Expert Verified Stock Movement Alerts - newser.com
Can Rigel Pharmaceuticals Inc. stock deliver strong Q4 earnings2025 Sector Review & Safe Capital Preservation Plans - newser.com
Is Rigel Pharmaceuticals Inc. stock recession proofEarnings Beat & Verified High Yield Trade Plans - newser.com
Published on: 2025-11-02 12:30:33 - newser.com
Rigel Gears Up to Report Q3 Earnings: Here's What to Expect - MSN
Can machine learning forecast Rigel Pharmaceuticals Inc. recoveryMarket Performance Summary & Risk Controlled Swing Alerts - newser.com
Measuring Rigel Pharmaceuticals Inc.’s beta against major indices2025 Macro Impact & Free Safe Capital Growth Stock Tips - newser.com
Finanzdaten der Rigel Pharmaceuticals-Aktie (RIGL)
Umsatz
Nettogewinn
Free Cashflow
ENV
0.64%
0.35%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):